Clinical Trials Logo

Fever clinical trials

View clinical trials related to Fever.

Filter by:

NCT ID: NCT01905098 Terminated - Hyperthermia Clinical Trials

Complementary and Alternative Medicine Sauna Detoxification Study: Phase I

Start date: July 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the impact of sauna use on polychlorinated biphenyls (PCB) in the blood of healthy human adults, as well as to assess safety, feasibility, and tolerability, and effects on quality of life and wellness. We hope to determine if there is a link between lower PCB levels in blood and sauna use.

NCT ID: NCT01817205 Terminated - Clinical trials for Hepatocellular Carcinoma

Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma

Start date: March 2013
Phase: N/A
Study type: Interventional

The objective is to evaluate the safety and therapeutic effect of combined hyperthermia and TACE for unresectable HCC

NCT ID: NCT01685632 Terminated - Clinical trials for Peritoneal Carcinomatosis From Colorectal or Ovarian Origin

Intra Peritoneal Chemo Hyperthermia (IPCH) : Cellular and Metabolic Consequences

CHIP
Start date: September 2012
Phase: N/A
Study type: Interventional

Intra Peritoneal Chemo Hyperthermia (IPCH) is a recently validated option for the treatment of peritoneal carcinomatosis from colorectal or ovarian origin. This therapeutic program demonstrated a significant improvement of the late stages (i.e. carcinomatosis) of the disease. From a clinical point of view, within the first 24 hours after IPCH, patients undergo a systemic inflammatory response syndrome, and therefore require to be monitored in an intensive care unit. From a metabolic perspective, preliminary data have been shown a significant "anaerobic style" disturbance of energetic metabolism, suggesting a deep cellular energetic deficit throughout IPCH process. Putative contradictory effects of IPCH, like the increase of chemotherapy-related cellular toxicity due to heat and on the other hand the initiation of a stress protein response (heat shock response) which helps to reduce the cell injuries, leads to conduct a research project on the underlying mechanisms: consequences, in terms of patient's care and follow-up, are of high relevance. The primary goal is a multimodal assessment of the IPCH-related cell modifications: signaling pathways, apoptosis and antitumoral immune response. The assessment criteria include Heat shock protein expression (blood/cell ratio) compared to baseline values, apoptosis and immune response before/after IPCH. The scheduled sample size is 30 patients having an IPCH and 30 patients contraindicated per surgery.

NCT ID: NCT01618591 Terminated - Clinical trials for Acute Watery Diarrhea

Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea

TrEAT TD
Start date: September 2012
Phase: N/A
Study type: Interventional

The purpose of the trial is to develop the evidence on relative efficacy of 3 available single-dose loperamide adjuncted regimens for watery diarrhea and a single-dose regimen, with and without loperamide, for dysentery/febrile diarrhea required for informing decisions among these regimens. Information from this study will be used to develop management guidelines for the diagnosis and management of travelers' diarrhea (TD) among deployed United States and United Kingdom military personnel.

NCT ID: NCT01370044 Terminated - Febrile Seizure Clinical Trials

Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures

CARDIF
Start date: August 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this clinical trail is to evaluate the efficacy of a Carbogen inhalation in patients with febrile seizures compared to a placebo-inhalation. Further aims are the evaluation of the safety of the Carbogen inhalation via a low-pressure can with a breathing mask in a home-setting, the manageability of the Carbogen inhalation via a low pressure can with a breathing mask in a home-setting or on the way (mobility), the quality of life of the parents and children using the low pressure can with a breathing mask in a home-setting or on the way (mobility) and the contentment and anxiety of the parents.

NCT ID: NCT01287143 Terminated - Fever Clinical Trials

Quantifying and Understanding the Signs and Symptoms of Fever

Start date: January 13, 2011
Phase: N/A
Study type: Observational

Background: - Fever is a common symptom of illness, but it can involve many signs (a signal that something is not right in the body that can be seen by others, such as vomiting) and symptoms (a signal that something is not right in the body that are felt only by the person, such as pain) that may differ depending on the type of illness involved. Researchers are interested in studying individuals who have a fever to examine how often these signs and symptoms are experienced by patients. Objectives: - To identify and evaluate the signs and symptoms of fever and examine their frequency in individuals who have fever. Eligibility: - Individuals at least 8 years of age who are admitted to the NIH Clinical Center and have a fever (body temperature of at least 38 degrees Celsius/100.4 degrees Fahrenheit). Design: - Participants will be screened upon admission to the NIH Clinical Center. - Researchers will review the Clinical Center admission records. - Participants will complete a 15- to 20-minute survey with questions about how they are feeling and what symptoms they have experienced before, during and after an episode of fever.

NCT ID: NCT01144442 Terminated - Ovarian Cancer Clinical Trials

WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer

Start date: July 27, 2010
Phase: N/A
Study type: Interventional

This is an open-label, pilot study in patients with a diagnosis of recurrent ovarian, fallopian tube or primary peritoneal carcinoma who have undergone standard cytoreductive surgery following by adjuvant chemotherapy. It is expected that this first surgery was optimal - as defined as no residual tumor > or = 1 centimeter. Patient has clinical evidence of a first recurrence. The patient undergoes surgery and isotonic normal saline (perfusate) heated and administered into the abdomen, followed by hyperthermic intraperitoneal chemotherapy infusion (HIPC) administering carboplatin (chemotherapy). Six weeks after surgery patients will receive adjuvant chemotherapy with Paclitaxel and Carboplatin for 6 cycles.

NCT ID: NCT01019980 Terminated - Fever Clinical Trials

Efficacy of Diclofenac Potassium Versus Acetaminophen in Febrile Children With Acute Upper Respiratory Tract Infections

Start date: March 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess if a single dose of Diclofenac potassium (0.5 mg/kg) is more or as effective as a single dose of Acetaminophen (10 mg/kg) in the reduction of fever during 2 hours, in the treatment of febrile children with acute upper respiratory infections. This is a comparative double blind, double dummy, randomized study on the effectiveness of Diclofenac potassium versus Acetaminophen in febrile children with acute upper respiratory tract infections. The patient will be randomized to either group: Group A (Diclofenac potassium (0.5 mg/kg) or Group B (Acetaminophen (10 mg/kg)). A Health Care Professional trained will measure the temperature during 2 hours. During the study period, parents or legal representatives will be invited to fill a survey about the habits and knowledge regarding fever management at home.

NCT ID: NCT00958776 Terminated - Headache Clinical Trials

A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza

Start date: November 2009
Phase: Phase 3
Study type: Interventional

A Phase 3, multicenter, randomized, double-blind, controlled study to evaluate the efficacy and safety of peramivir administered intravenously in addition to standard of care compared to standard of care alone in adults and adolescents who are hospitalized due to serious influenza.

NCT ID: NCT00927953 Terminated - Meningitis Clinical Trials

Treatment of West Nile Virus With MGAWN1

PARADIGM
Start date: May 2009
Phase: Phase 2
Study type: Interventional

This study will test a drug called MGAWN1 for the treatment of West Nile infections.